JNJ vs GILD
By Alex · Tickerpine
Johnson & Johnson vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | GILD |
|---|---|---|
| Price | $285.75 | $168.08 |
| Market cap | $687.89B | $208.48B |
| P/E ratio | 43.4 | — |
| ROE | 20.02% | -22.45% |
| Profit margin | 16.20% | -12.46% |
| Revenue growth | 5.90% | 6.80% |
| Dividend yield | 1.88% | 1.95% |
| Beta | 0.20 | 0.37 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs GILD in plain English
- JNJ is the bigger company — about 3.3× the market cap of GILD.
- JNJ earns a higher return on equity (20% vs -22%).
- GILD is growing revenue faster (7% vs 6%).
- GILD has the higher dividend yield (1.95% vs 1.88%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.